MET-IN-1
MET-IN-1 (Compound 13) is an orally active MET inhibitor. MET-IN-1 has antitumor activity[1].
Product Specifications
UNSPSC
12352005
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/met-in-1.html
Smiles
O=C(NC(C=C1F)=C(C=C1N(C2=NC=CN3C2=CC=N3)[C@H]4C[C@@H](C4)C5=NN(C=C5)C)F)C6=CC=NN(C6=O)C7=NC=C(C=C7)F
Molecular Formula
C30H23F3N10O2
Molecular Weight
612.56
References & Citations
[1]Bumpers QA, et al. Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy. J Med Chem. 2024 Aug 1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2163719-01 0.1 mL
APC_Cy7-Linked Monoclonal Antibody to Lymphocyte Antigen 75 (LY75)
Ask
View Details MBS2163719-02 0.2 mL
APC_Cy7-Linked Monoclonal Antibody to Lymphocyte Antigen 75 (LY75)
Ask
View Details 
MBS2163719-03 0.5 mL
APC_Cy7-Linked Monoclonal Antibody to Lymphocyte Antigen 75 (LY75)
Ask
View Details